BXP Q3 EPS $2.29 beats mid-point by $1.54; FFO $1.91; 2023 guidance lower

BXP, Inc.

2022-Q3 EPS reported $4.62 revenue$2,318,757,000

Revenue $790.5M (+8.3% YoY); net income $361M ($2.29 EPS); FFO $299.8M ($1.91).
EPS beat included $1.50 gain on sale of 601 Mass Ave ($531M gross); FFO beat by $0.04.
FY2022 EPS guidance $5.55-$5.57, FFO $7.51-$7.53; FY2023 EPS $2.27-$2.42, FFO $7.15-$7.30.
Leased 1.4M SF in Q3; acquired 125 Broadway lab in Kendall Sq for ~$592.4M; disposed 601 Mass Ave and land parcels.
Agreed to acquire ~27% interest in 200 Fifth Ave, NYC for ~$280.2M and sell Avant residential for ~$141M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.